Questions to Ask Your Doctor or Research Office Nurse

  • What is the purpose of the study – is it to determine a new drug or suggest a new combination of drugs/treatment? 
  • Who has reviewed and approved the study? 
  • How are study results and safety of participants being checked? 
  • What kinds of therapies, procedures and/or tests will I have during the trial? 
  • How will the trial affect my current treatment plan and affect my daily life?
  • Will I be taken off my current treatment or will I continue to take my regular medications while in the trial?
  • Where will I have my medical care, and who will be in charge of my care? 
  • If the person in charge of my medical care during the trial is different from my current doctor, what will be the communication/interaction between the two? 
  • What are the benefits to my treatment and my health connected with this trial?
  • What are the potential short-term and long term risks connected with this trial?
  • Can I talk to other people in the study? 
  • What is the procedure for quitting the study once I have started it?
  • Will there be costs to me if I participate?
  • Will my insurance cover the costs?
  • What are my responsibilities if I participate?
  • How long will I be in the study?

Spotlight

Hear from Dr. Anil Sood, the Foundation’s Research Chairman, and Carol Brown, 2014 SGO Program Chair, about research of interest to women and the public presented at the 2014 SGO Annual Meeting on Women’s Cancer. Watch the video

Awareness

A new SGO Clinical Practice Statement states women diagnosed with epithelial ovarian, tubal, and peritoneal cancers should be considered for genetic counseling and testing, even in the absence of a family history.

Education

The next Gynecologic Cancer Survivors Course Friday, May 2, 2014 in Long Island, NY. For more information on courses, click here.